Mizzou Students Throw Support Behind Medical Pot Initiative: 'It's Just a Plant'
*By Carlo Versano*
On Tuesday, Missouri could become the 32nd state in the U.S. to legalize medical marijuana.
On the ballot are three proposals on the issue ー regarding regulation, taxation, and the distribution of tax revenues. The amendments are byzantine and confusing, but if one passes, medical marijuana will become the law of the land in the "Show-Me" State.
Cannabis legalization has garnered more public support in recent years, and medical pot is often thought to be the gateway to fuller legalization. While the Missouri medical community is [split](https://kcmedicine.org/survey-results-physician-attitudes-medical-marijuana/) on the drug's medicinal value, much of the student body at the University of Missouri has a pro-legalization stance.
CheddarU went to Mizzou's campus to hear what students had to say ahead of the vote.
"I just can't see any good reason not to have it medicinally available here," said In'lana Henderson, VP of Students for Sensible Drug Policy at Mizzou.
"People think that it's very taboo here," she added.
That possibility that Missouri, a reliably red state in the country's heartland, could pass a progressive drug law, gives some students hope that the end result could galvanize public support for cannabis legalization.
"I think that if we can legalize it, it will help other states do that, too," freshman Payton Nichols-Pittman said.
Or, as senior Meg Rogers put it: "It's just something that we don't need to make people feel bad for."
She added: "It's just a plant."
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street. This week we highlight Rivian, Costco, Nokia, Wyndham Hotels & Resorts, Choice Hotels and Rite Aid
Spirit Airlines canceled about 100 flights on Friday after pulling some planes out of service for inspections, and the airline expects the disruptions to last several days.
CVS Health is pulling from its shelves some cough-and-cold treatments that contain an ingredient that has been deemed ineffective by doctors and researchers.
It's almost that time of year - it's open enrollment season. Nate Black, vice president of health solutions product development with Voya Financial, joined Cheddar News to explain the critical decision-making needed when choosing the best coverage for you and your family.
Elon Musk announced two new subscription tiers for people who want the premium experience. This, as some users in some countries may have to pay a very small fee to access the platform for more. Cheddar News' senior reporter Michelle Castillo explains.
